CN1062722C - 双纤维降糖粉及其制造方法 - Google Patents
双纤维降糖粉及其制造方法 Download PDFInfo
- Publication number
- CN1062722C CN1062722C CN97105767A CN97105767A CN1062722C CN 1062722 C CN1062722 C CN 1062722C CN 97105767 A CN97105767 A CN 97105767A CN 97105767 A CN97105767 A CN 97105767A CN 1062722 C CN1062722 C CN 1062722C
- Authority
- CN
- China
- Prior art keywords
- sugar
- sodium alginate
- sugar reducing
- reducing powder
- wheat bran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000835 fiber Substances 0.000 title claims abstract description 10
- 239000000843 powder Substances 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 title claims description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 15
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 10
- 239000000661 sodium alginate Substances 0.000 claims abstract description 10
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 10
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 5
- 235000015165 citric acid Nutrition 0.000 claims abstract description 5
- 229960004106 citric acid Drugs 0.000 claims abstract description 5
- 229940013618 stevioside Drugs 0.000 claims abstract description 5
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000019202 steviosides Nutrition 0.000 claims abstract description 5
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000012141 vanillin Nutrition 0.000 claims abstract description 5
- 229940117960 vanillin Drugs 0.000 claims abstract description 5
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 238000010025 steaming Methods 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims 2
- 235000010469 Glycine max Nutrition 0.000 abstract description 7
- 244000068988 Glycine max Species 0.000 abstract description 7
- 235000015099 wheat brans Nutrition 0.000 abstract description 7
- 235000013402 health food Nutrition 0.000 abstract description 6
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 210000002700 urine Anatomy 0.000 abstract description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 3
- 239000008103 glucose Substances 0.000 abstract description 3
- 102000004169 proteins and genes Human genes 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 3
- 239000001913 cellulose Substances 0.000 abstract description 2
- 229920002678 cellulose Polymers 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 230000036186 satiety Effects 0.000 abstract description 2
- 235000019627 satiety Nutrition 0.000 abstract description 2
- 210000001015 abdomen Anatomy 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229960004580 glibenclamide Drugs 0.000 description 2
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 208000022530 polyphagia Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种双纤维降糖粉，其特征是由麦麸、黑大豆、海藻酸钠、甜菊甙、拧檬酸和香兰素所组成，它们的重量百分数分别是65～90、14～25、1～10、0.01～1、0.01～1和0.01～1。制造时将麦麸、黑大豆、海藻酸钠和3种调味剂粉碎、混合、烘干、焙烤即可。本发明的保健食品无糖、无毒、无害，蛋白质和食物纤维素含量高，价格便宜，可延缓糖吸收、改善糖耐量、降低血糖和尿糖的浓度，同时能使患者有显著的饱腹感。
Description
本发明涉及一种保健食品，更具体地说涉及一种含海藻酸钠的保健食品。
糖尿病患者用消渴丸治疗，这是一种由中药和优降糖组成的丸剂，它主要通过促进血清胰岛素的分泌和抑制胰高血糖素的分泌，增加肝糖原含量，而达到缓解多饮、多尿、多食、消瘦、体倦无力、睡眠差、腰痛、尿糖和血糖升高等症状。消渴丸以中药和优降糖为原料，不但成本高，而且还能使人体的免疫功能低下，出现低血糖等毒副作用。
本发明的目的在于提供一种双纤维降糖粉，这种食品完全由天然物质配制，它能弥补现有保健食品的上述不足。
本发明的双纤维降糖粉其特征是由麦麸、黑大豆、海藻酸钠、甜菊甙、柠檬酸和香兰素所组成，它们的重量百分数分别是65～90、14～25、1～10、0.01～1、0.01～1和0.01～1，各成份之和为100％。
制造双纤维降糖粉的方法特征是将麦麸和海藻酸钠粉碎至80目，在蒸车内0.05MPa和140～160℃下蒸煮0.5～1.5小时；将黑大豆炒过之后粉碎至80目，将三者混合搅拌30～50分钟，然后加入甜菊甙、柠檬酸和香兰素，将混合物料在80～100℃下烘干，在130～160℃下焙烤20～40分钟。
本发明的保健食品无糖、无毒、无害，蛋白质和食物纤维素含量高，价格便宜，可延缓糖吸收、改善糖耐量、降低血糖和尿糖的浓度，同时能使患者有显著的饱腹感并改善口渴、多饮、多食、多尿、易饥、乏力等症状。
下面通过实施例说明本发明。
实施例
本发明的双纤维降糖粉按下述方法和步骤制造：
1.将新鲜麦麸除掉大部分淀粉，磨碎，过80目筛后，均匀装盘，在蒸车内0.05MPa和140～160℃下蒸煮1小时，然后室温下凉干，同时将大块铲碎，去杂质，然后造粒，使颗粒均匀。
2.将颗粒饱满、均匀的黑大豆，挑去杂质，清洗晾干后焙炒，控制温度与时间，避免夹生、炒糊，然后粉碎，细度达80目。
3.将海藻酸钠粉碎达80目细度，在蒸车内0.05MPa，140～160℃下蒸煮1.5小时，除去杂味，降低粘度，凉干后焙烤(180℃)1.5小时。
4.将已处理好的物料79.86kg麦麸、17kg要粉、3kg海藻酸钠混合搅拌40分钟，然后加调味剂辅料0.06kg甜菊甙、0.05kg柠檬酸和0.03kg香兰素，再搅20分钟，使物料混匀。
5.将混匀物料烘干，烘干温度为80～100℃，焙考温度为140℃，时间30分钟，严格控制水份，中控水份指标合格后方可包装。
6.包装时需防止微生物的污染，包装车间应定期用紫外线杀菌消毒。
本保健食品中所含的海洋生物提取物海藻酸钠属天然高分子化合物，为可溶性食物纤维，有粘性，不被吸收，在人体肠道内可形成一种凝胶过滤系统，麦麸含有大量的非溶性食物纤维、丰富的维生素和对糖尿病患者有益的微量元素，黑大豆含有丰富的蛋白质和大量的非溶性粗纤维，这些粗纤维在肠道下段可被微生物利用发酵。把这3种物质按上述方法配制在一起，它们相互作用，从而具有显著的延缓糖吸收，改善糖耐量，降低血糖、尿糖的作用，同时增加了组织对胰岛素的敏感性，对非胰岛素依赖型糖尿病患者更为适应，并且还能代食消饥，减轻因控制饮食而产生的饥饿感；此外，在降低胆固醇、延缓糖吸收、通便方面也具有重要意义。
本发明的双纤维降糖粉亦称为降糖乐，适于高血糖、糖尿病患者食用，但不能代替药物治疗。加开水将其调成糊状后即可食用，每日2～3次，每次25～30克。
Claims (2)
1.一种双纤维降糖粉，其特征是由麦麸、黑大豆、海藻酸钠、甜菊甙、柠檬酸和香兰素所组成，它们的重量百分数分别是65～90、14～25、1～10、0.01～1、0.01～1和0.01～1，各成份之和为100％。
2．制造权利要求1所述的双纤维降糖粉的方法，其特征是将麦麸和海藻酸钠粉碎至80目，在蒸车内0.05MPa和140～160℃下蒸煮0.5～1.5小时；将黑大豆炒过之后粉碎至80目，将三者混合搅拌30～50分钟，然后加入甜菊甙、柠檬酸和香兰素，将混合物料在80～100℃下烘干，在130～160℃下焙烤20～40分钟。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97105767A CN1062722C (zh) | 1997-04-04 | 1997-04-04 | 双纤维降糖粉及其制造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97105767A CN1062722C (zh) | 1997-04-04 | 1997-04-04 | 双纤维降糖粉及其制造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1195486A CN1195486A (zh) | 1998-10-14 |
| CN1062722C true CN1062722C (zh) | 2001-03-07 |
Family
ID=5168071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97105767A Expired - Fee Related CN1062722C (zh) | 1997-04-04 | 1997-04-04 | 双纤维降糖粉及其制造方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1062722C (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2762121A1 (en) * | 2000-02-01 | 2001-08-09 | Stevia Aps | The use of bicyclo [3.2.1]octan or kaurene for the treatment of non-insulin dependent diabetes mellitus, hypertension and metabolic syndrome |
| EP1361870A2 (en) * | 2001-02-01 | 2003-11-19 | Nutri Pharma ASA | A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097135A (zh) * | 1993-07-07 | 1995-01-11 | 长岛县海洋药物研究所 | 斯丽姆减肥宝 |
| CN1144060A (zh) * | 1995-08-25 | 1997-03-05 | 兰进 | 一种海藻降糖食品 |
-
1997
- 1997-04-04 CN CN97105767A patent/CN1062722C/zh not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097135A (zh) * | 1993-07-07 | 1995-01-11 | 长岛县海洋药物研究所 | 斯丽姆减肥宝 |
| CN1144060A (zh) * | 1995-08-25 | 1997-03-05 | 兰进 | 一种海藻降糖食品 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1195486A (zh) | 1998-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1054703A (zh) | 减肥米的制造方法 | |
| CN1144050A (zh) | 降糖功能食品 | |
| WO1988008257A1 (fr) | Aliment facilitant l'activite intestinale | |
| CN108391692A (zh) | 一种高纤维豆酥糕点的制作方法 | |
| CN105851165A (zh) | 一种保健广式五仁叉烧月饼及其制作方法 | |
| CN107927534A (zh) | 一种低血糖生成指数的冲调纤维粉及其制备方法 | |
| CN111642702A (zh) | 一种适合糖尿病人及体重超重者食用的高膳食纤维高蛋白鸡胸肉肠及其制备方法 | |
| CN103404778A (zh) | 一种苦荞面 | |
| CN111838534B (zh) | 一种藜麦质低gi配料的制备方法 | |
| CN1324977C (zh) | 保健中草药软糖及其制造方法 | |
| CN112450252A (zh) | 一种增强饱腹感的代餐冷加工糕点及其制备方法 | |
| CN109393309A (zh) | 一种低gi燕麦代餐粉及其制作方法 | |
| CN1062722C (zh) | 双纤维降糖粉及其制造方法 | |
| CN1269973A (zh) | 一种降糖营养饼干及其制造方法 | |
| CN105942538A (zh) | 利用桑叶生产膳食纤维的方法 | |
| CN107347959A (zh) | 一种适合糖尿病人长期服用的无糖蛋糕及其制备方法 | |
| CN110063503A (zh) | 一种具有降糖作用的天然膳食纤维补充剂及其制备方法 | |
| CN1037145C (zh) | 糖尿病功能食品添加配合料 | |
| CN112262987A (zh) | 发酵膳食纤维复配益生菌代餐粉 | |
| TW202034790A (zh) | 苦瓜肽組合物 | |
| CN108095054B (zh) | 一种减少膳食中糖分消化和吸收的植物性胶囊及其制备方法 | |
| CN102150779B (zh) | 一种调节及稳定血糖的保健食品及制备方法 | |
| CN112167633B (zh) | 一种鲜梨除糖梨渣及其提取物 | |
| CN117678743A (zh) | 一种增强饱腹感且保护胃黏膜的原料组合物及制备方法 | |
| CN112514951B (zh) | 一种白果功能饼干及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |